Spironolactone
Aldactone, Carospir (spironolactone) is a small molecule pharmaceutical. Spironolactone was first approved as Aldactone on 1982-12-30. It is used to treat ascites, edema, heart failure, hirsutism, and hyperaldosteronism amongst others in the USA. The pharmaceutical is active against mineralocorticoid receptor. Aldactone's patent is valid until 2036-10-28 (FDA).
| Trade Name | Aldactone, Carospir |
|---|---|
| Common Name | Spironolactone |
| Indication | ascites, edema, heart failure, hirsutism, hyperaldosteronism, hypertension, hypokalemia |
| Drug Class | Antimineralocorticoid; Steroidal antiandrogen |
